| CANDRIAM EQUITIES L BIOTECHNOLOGY, R-H - CAPITALISATION |
    
|
|
| DAX | 25.274,59 | 386,03 | 1,55% |
| TecDax | 4.070,12 | 34,03 | 0,84% |
| MDAX | 32.715,22 | 606,95 | 1,89% |
| Dow Jones (EOD) | 50.579,70 | 294,04 | 0,58% |
| Nasdaq 100 | 29.481,64 | 124,37 | 0,42% |
| S & P 500 (EOD) | 7.473,47 | 27,75 | 0,37% |
| SMI | 13.503,21 | 56,78 | 0,42% |
|
| EUR/US$ | 1,1644 | 0,00 | 0,35% |
| EUR/Yen | 185,0447 | 0,33 | 0,18% |
| EUR/CHF | 0,9107 | -0,00 | -0,02% |
| EUR/Brit. Pfund | 0,8625 | -0,00 | -0,14% |
| Yen/US$ | 0,0063 | 0,00 | 0,03% |
| CHF/US$ | 1,2786 | 0,00 | 0,03% |
|
| baha Brent Indication | 95,79 | -4,95 | -4,91% |
| Gold | 4.567,06 | 58,78 | 1,30% |
| Silber | 77,61 | 2,09 | 2,76% |
| Platin | 1.950,20 | 19,84 | 1,03% |
| |
|
|
290,20 
